About Limula
Limula is a company founded in 2020 by Luc Henry and Yann Pierson.. Limula has raised $6.8 million across 4 funding rounds from investors including University of Oxford, Open-i and Life Extension Ventures. Limula offers products and services including Unified Manufacturing Platform and Cell Processing Unit. Limula operates in a competitive market with competitors including PBS Biotech, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others.
- Founders Luc Henry, Yann Pierson
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Limula Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.8 M (USD)
in 4 rounds
-
Latest Funding Round
$6.8 M (USD), Seed
May 21, 2024
-
Investors
University of Oxford
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Limula
Limula offers a comprehensive portfolio of products and services, including Unified Manufacturing Platform and Cell Processing Unit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated device combining bioreactor and centrifuge for therapy production
Modular system for scalable cell therapy development and processing
Unlock access to complete
Funding Insights of Limula
Limula has successfully raised a total of $6.8M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $6.8 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $6.8M
-
First Round
First Round
(16 Feb 2022)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Seed - Limula | Valuation | Life Extension Ventures | |
| Nov, 2022 | Amount | Grant - Limula | Valuation |
investors |
|
| Oct, 2022 | Amount | Seed - Limula | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Limula
Limula has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, Open-i and Life Extension Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on science and tech-driven startups
|
Founded Year | Domain | Location | |
|
Zühlke is recognized as a global transformation partner focused on engineering and innovation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Limula
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Limula
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Limula Comparisons
Competitors of Limula
Limula operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PBS Biotech, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| domain | founded_year | HQ Location |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for cell and gene therapies
|
|
| domain | founded_year | HQ Location |
Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications.
|
|
| domain | founded_year | HQ Location |
Contract research and discovery services are provided to biopharma firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Limula
Frequently Asked Questions about Limula
When was Limula founded?
Limula was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Who is the current CEO of Limula?
Luc Henry is the current CEO of Limula. They have also founded this company.
Is Limula a funded company?
Limula is a funded company, having raised a total of $6.8M across 4 funding rounds to date.
What does Limula do?
Limula was founded in 2020 as a provider of modular solutions for on-demand and scaled manufacturing of cell therapies. Operations focus on a proprietary bioreactor platform that integrates multiple manufacturing steps into a single automated device, supported by end-to-end process analytics. The company operates in the biotechnology sector, with services centered on cell therapy production efficiency. Based in Switzerland, as indicated by its domain.
Who are the top competitors of Limula?
Limula's top competitors include PBS Biotech, m2p-labs and Membio.
What products or services does Limula offer?
Limula offers Unified Manufacturing Platform and Cell Processing Unit.
Who are Limula's investors?
Limula has 9 investors. Key investors include University of Oxford, Open-i, Life Extension Ventures, Verve Ventures, and Zühlke.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.